Applied DNA Reschedules Investor Call to Honor Jimmy Carter

Applied DNA Sciences, Inc., known for its PCR-based technologies, has postponed its Investor Update call. Originally set for January 9, 2025, the call will now take place on February 13, 2025, aligning with the release of its Q1 fiscal 2025 financial results.

This change honors the National Day of Mourning for the passing of former President Jimmy Carter. The event aims to provide updates on the company’s strategic restructuring announced in December 2024 and its Good Manufacturing Practice (GMP) initiative.

The company operates in key areas including synthetic DNA manufacturing for nucleic acid therapeutics, DNA/RNA detection in diagnostics, and industrial supply chain security. The decision reflects Applied DNA's respect for national observances while maintaining transparency with its stakeholders.